Applicability of Recent Dyslipidemia Guidelines in Clinical Practice

https://doi.org/10.22146/aci.47682

Erwinanto Erwinanto(1*)

(1) Department of Cardiology and Vascular Medicine, Cardiovascular Division, Department of Internal Medicine, Universitas Padjajaran – Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
(*) Corresponding Author

Abstract


Atherosclerotic plaque rupture is closely related to acute coronary syndromes.Stabilization of atherosclerotic plaque which slashes plaque rupture is as importantas regression ofplaque size for reducing cardiovascular events. Dyslipidemia therapy targeting to decrease LDL cholesterol reduces cardiovascular events such as acute myocard infarct, stroke, and death which are suggested to be the result of plaque stabilization. Dyslipidemia therapy also regress atherosclerotic plaque into a smaller volume. Plaque regression improves coronary flow responsible for the reduction of myocardial infarction incidence in patients with coronary heart disease (CHD).This paper consists of two parts. The first part discusses the evidence of cardiovascular event reduction with statin. The second part describes dyslipidemia management based on the 2017 Indonesian Heart Association (PERKI) Guideline on the Management of Dyslipidemia

Full Text:

PDF



DOI: https://doi.org/10.22146/aci.47682

Article Metrics

Abstract views : 1435 | views : 2107

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Erwinanto Erwinanto

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



ACI (Acta Cardiologia Indonesiana) is indexed by: 

   

  

ACI (Acta Cardiologia Indonesiana) is published by:

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Address: Radiopoetro Building 2nd Floor, West Wing, Farmako Street, Sekip, Yogyakarta, Indonesia 55281

ACI (Acta Cardiologia Indonesiana) is endorsed by: